Effects of Antidepressant Treatment with Clomipramine on Hormonal Responses to Thyrotropin-Releasing Hormone and Insulin-induced Hypoglycemia: Implications for the "Monoamine-Hypothesis"*

Neuroendocrine test were carried out to study effects of clomipramine treatment in 24 unipolar depressed women. Clomipramine (50-150 mg/day) increased the response of prolactin and thyrotropin to stimulation by thyrotropin-releasing hormone (TRH), while no response of growth hormone (HGH) to TRH was seen. Clomipramine decreased the response of HGH to insulin, while the responses of prolactin and cortisol to insulin were not affected. The findings suggest that the neuroendocrine and antidepressant effects of clomipramine cannot be accounted for entirely on the basis of monoaminergic mechanisms.

[1]  W. Mendelson,et al.  The regulation of insulin-induced and sleep-related human growth hormone secretion: A review , 1979, Psychoneuroendocrinology.

[2]  M. Åsberg,et al.  Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression , 1979, Clinical pharmacology and therapeutics.

[3]  G. Langer,et al.  Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men , 1978, Psychoneuroendocrinology.

[4]  W. Ganong,et al.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion. , 1978, Physiological reviews.

[5]  G. Ponsin,et al.  Participation of serotonin in thyrotropin release. I. Evidence for the action of serotonin on thyrotropin releasing hormone release. , 1978, Endocrinology.

[6]  P. Greengard,et al.  Brain histamine receptors as targets for antidepressant drugs , 1978, Nature.

[7]  J. Nerup,et al.  Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression , 1977, Psychoneuroendocrinology.

[8]  I. Wilson,et al.  Thyroid stimulating hormone response after thyrotropin releasing hormone in depressed, schizophrenic and normal women , 1977, Psychoneuroendocrinology.

[9]  F. Grégoire,et al.  Hormone release in depressed patients before and after recovery , 1977, Psychoneuroendocrinology.

[10]  C. Invitti,et al.  Effects of a gamma aminobutyric acid (GABA) derivative, baclofen, on growth hormone and prolactin secretion in man. , 1977, The Journal of clinical endocrinology and metabolism.

[11]  P. Woolf,et al.  Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion. , 1977, The Journal of clinical endocrinology and metabolism.

[12]  J. Takahara,et al.  Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. , 1977, The Journal of clinical endocrinology and metabolism.

[13]  A. Pontiroli,et al.  Effect of the antihistaminic agents meclastine and dexchlorpheniramine on the response of human growth hormone to arginine infusion and insulin hypoglycemia. , 1976, The Journal of clinical endocrinology and metabolism.

[14]  J. Birkenhäger,et al.  Effect of bromocriptine in pituitary-dependent Cushing's syndrome. , 1976, The Journal of endocrinology.

[15]  C. Invitti,et al.  Effect of an antiserotoninergic drug, metergoline, on the ACTH and cortisol response to insulin hypoglycemia and lysine-vasopressin in man. , 1976, The Journal of clinical endocrinology and metabolism.

[16]  S. Lal,et al.  Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. , 1975, The Journal of clinical endocrinology and metabolism.

[17]  N. Norlem,et al.  PROGNOSTIC VALUE OF THYROTROPIN‐ RELEASING HORMONE STIMULATION TEST IN ENDOGENOUS DEPRESSION , 1975, Acta psychiatrica Scandinavica.

[18]  P. Cryer,et al.  Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion. , 1975, The Journal of clinical investigation.

[19]  M. L'hermite,et al.  Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia. Inhibition of prolactin release. , 1975, The Journal of clinical endocrinology and metabolism.

[20]  R. Utiger,et al.  Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations. , 1975, The Journal of clinical endocrinology and metabolism.

[21]  F. Azizi,et al.  Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations. , 1974, The Journal of clinical investigation.

[22]  J. Feldman,et al.  Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine. , 1974, The Journal of clinical endocrinology and metabolism.

[23]  J. Felber,et al.  Effects of adrenaline on insulin-induced release of growth hormone and cortisol in man. , 1974, Acta Endocrinologica.

[24]  W. Waldhäusl,et al.  Development of antibodies to human growth hormone (HGH) in children of short stature treated with HGH. , 1971, Acta endocrinologica.

[25]  W. Blackard,et al.  Cholinergic Blockade and Growth Hormone Responsiveness to Insulin Hypoglycemia∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  A. Rogol,et al.  Effect of cyproheptadine on TRH-stimulated prolactin and TSH release in man. , 1977, The Journal of clinical endocrinology and metabolism.

[27]  H. Burger,et al.  Chapter 3 – TSH and TRH: Their Physiological Regulation and the Clinical Applications of TRH , 1977 .